Medical News Today: What is spongiotic dermatitis?
Learn about spongiotic dermatitis, a skin condition related to eczema that causes swelling under the skin. We look at the symptoms and treatment options.
Conditions: Dermatitis; Dermatitis, Atopic; Eczema; Skin Diseases; Skin Diseases, Genetic; Genetic Diseases, Inborn; Skin Diseases, Eczematous; Hypersensitivity; Hypersensitivity, Immediate; Immune System Diseases Interventions: Drug: PF-04965842 100 mg; Drug: PF-04965842 200 mg; Drug: Placebo Sponsor: Pfizer Recruiting
Abstract Chemical allergens are small molecules able to form a sensitizing complex once they bound to proteins. One of the most frequent manifestations of chemical allergy is contact hypersensitivity, which can have serious impact on quality of life. Allergic contact dermatitis is a predominantly CD8 + T cell-mediated immune disease, resulting in erythema and eczema. Chemical allergy is of considerable importance to the toxicologist, who has the responsibility of identifying and characterizing the allergenic potential of chemicals, and estimating the risk they pose to human health. This review aimed ...
Conditions: Eczema; Atopic Dermatitis; Atopic Dermatitis and Related Conditions Interventions: Other: Bubbles; Other: Bleach and Bubbles Sponsor: University of North Carolina, Chapel Hill Recruiting
Strata Skin Sciences (NSDQ:SSKN) said yesterday it won FDA 510(k) clearance for the Multi-Micro Dose tip designed for use with its Xtrac 308nm excimer laser. The newly cleared tip is indicated for use in conjunction with the Horsham, Penn.-based company’s Xtrac laser system to filter narrow band UVB light at delivery, intended to individualize non-blistering doses during procedures. The MMD tip is designed to apply multiple level doses of energy to the patient’s psoriatic plaque to identify maximum sub-blistering energy dose for treatment zones so that physicians can design an optimal dose for each patient...
Conclusion: We suggest that EPO is a safe and effective medicine for Korean patients with mild AD. PMID: 30065580 [PubMed]
FRIDAY, Aug. 3, 2018 -- Physicians can create an adherence protocol for patients, particularly children and teens, receiving treatment for atopic dermatitis, according to an article published in Dermatology Times. Lack of adherence to treatment...
Introduction: Eczema coxsackium, first described in 1968 by Nahmias and colleagues, represents a form of hand foot and mouth disease (HFMD) characterized by vesicles and erosions in areas affected by atopic dermatitis. More recently, cases of this condition have been reported in the literature due to the importance of distinguishing it from eczema herpeticum. Early PCR for accurate diagnosis of eczema coxsackium strains A6, and in some cases A16, would allow providers to potentially avoid treatment with acyclovir or antibiotics.
Atopic dermatitis or eczema (AD-E) is associated with acute flares, intractable pruritus and comorbid health conditions, all of which may prompt urgent care visits. We sought to determine the predictors of emergency room visits for AD-E in the U.S. Data were analyzed from the Nationwide Emergency Department (ED) Sample, including a ∼20% sample of all U.S. emergency department visits. There were 1,857,689 weighted ED visits with a primary diagnosis of AD-E. In bivariate logistic regression models, ED visits with vs.